Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest high cholesterol Stories

2011-08-24 09:00:00

SAINT PAUL, Minn., Aug. 24, 2011 /PRNewswire/ -- Even as the costs of brand-name prescription drugs and commercial health care rose sharply in 2010, pharmacy spending at Prime Therapeutics (Prime) and its health plan partners rose just 2.9 percent, one of the smallest increases in the pharmacy benefit management (PBM) industry, according to the company's 2011 Drug Trend Insights report released today. Prime executives attributed the performance to several factors: industry-leading...

2011-08-15 06:35:00

KUALA LUMPUR, Malaysia, Aug. 15, 2011 /PRNewswire/ -- The leading website about lowering cholesterol naturally, All-About-Lowering-Cholesterol.com (http://www.all-about-lowering-cholesterol.com), unequivocally recommends that all patients with high cholesterol educate themselves on natural methods for lowering cholesterol, before they ever think of using any statin drug. This education becomes even more important now, since there are voices recommending that some statin drugs may be...

2011-07-20 00:00:31

Statins side effects are the main reason a reported 59% of all patients prescribed Statins therapy stop taking them within one year. The millions of Americans that are now going untreated can benefit from all natural therapies that have been shown to be safe, effective and affordable reports Solana Health. Solana Beach, CA (PRWEB) July 19, 2011 Today, statins side effects and their cost are the main reasons more than half of all patients prescribed statins therapy stop taking them within a...

2011-06-07 10:55:00

FRANKLIN LAKES, N.J., June 7, 2011 /PRNewswire/ -- Patients with high cholesterol who regularly take their cholesterol-lowering medications have significantly fewer hospitalizations from cardiovascular problems and can reduce their health care costs by as much as $944 over 18 months, according to research published in the June 1 issue of the American Journal of Cardiology. (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO) The study conducted by the Medco Research...

2011-05-11 06:15:00

HOERSHOLM, Denmark and SAN DIEGO, May 11, 2011 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that it has advanced a second drug from its cardiometabolic program, SPC4955 into Phase 1 clinical trials, for the treatment of high cholesterol. Developed using Santaris Pharma A/S proprietary Locked Nucleic Acid (LNA) Drug Platform, SPC4955 is a...

2011-05-04 06:15:00

HOERSHOLM, Denmark and SAN DIEGO, May 4, 2011 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that it has advanced SPC5001 into Phase 1 clinical trials for the treatment of high cholesterol. SPC5001 is a mRNA-targeted drug that inhibits the exciting new target, Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9), a protein involved in removing low density...

2011-04-19 14:21:00

RANCHO CORDOVA, Calif., April 19, 2011 /PRNewswire/ -- A new study released today shows that eye exams are often the first to detect chronic diseases like diabetes and hypertension. The study, conducted by Human Capital Management Services Group (HCMS), a national human capital consulting firm, found that eye doctors detected signs of certain chronic conditions before any other healthcare provider recorded the condition--65 percent of the time for high cholesterol, 20 percent of the...

2011-04-15 08:13:00

(Ivanhoe Newswire) -- Alzheimer's disease is the sixth leading cause of death in the U.S. and the only cause of death among the top 10 that cannot be prevented, cured or even slowed. However, treating high blood pressure, high cholesterol, diabetes and other vascular risk factors may help lower the risk of Alzheimer's disease in people who already show signs of declining thinking skills or memory problems. Researchers studied 837 people with mild cognitive impairment, the stage of memory loss...

2011-04-13 21:59:24

Treating high blood pressure, high cholesterol, diabetes and other vascular risk factors may help lower the risk of Alzheimer's disease in people who already show signs of declining thinking skills or memory problems. The research is published in the April 13, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology. Researchers followed 837 people with mild cognitive impairment, the stage of memory loss that often leads to Alzheimer's...

2011-04-12 07:15:00

CLEVELAND, April 12, 2011 /PRNewswire/ -- Neuroendocrinology Letters has just published a paper by the Dzugan Institute of Restorative Medicine entitled "Correction of steroidopenia as a new method of hypercholesterolemia treatment." In this study, Principle Investigator Sergey Dzugan, M.D., Ph.D., demonstrates that "correction of steroidopenia with anthropo-identical hormones" (bio-identical hormone restorative therapy or HT) can be an inexpensive and effective method of treatment for high...